About ScreenCell®
ScreenCell® is a French biotechnology company specializing in the microfiltration isolation of circulating tumor cells (CTCs) and their analysis using liquid biopsy.
Since 2010, we have been designing and developing CTC isolation kits for researchers, clinicians, and laboratories working on liquid biopsy and translational oncology.
Our solutions are based on a patented, user-friendly, standardized technology compatible with a wide range of analytical applications.
With over 70 scientific publications and a presence in more than 30 countries, ScreenCell is now an international leader in circulating tumor cell (CTC) isolation.
Our mission is based on a deep and unwavering commitment to revolutionizing cancer care.
We strive to advance treatment methods and improve patients’ quality of life, while constantly pushing the boundaries of oncology and liquid biopsy.
With a focus on a human-centered approach, we place paramount importance on listening to the needs of clinicians and researchers.
Through close collaboration with the scientific and medical communities, we transform every discovery into a valuable opportunity to save lives.
Since 2010, we have made it a priority to minimize our environmental footprint by adapting our production processes.
In particular, we have chosen not to use plastic in our packaging and to replace it with recyclable cardboard, in order to limit non-recyclable waste and reduce the use of plastic materials.
From design to manufacturing, we control the entire production process of our filtration systems to guarantee high-quality products while preserving the environment and natural resources.
You’ve come to the right place!
Fill in the fields below and we’ll take care of the rest.
Follow ScreenCell® on LinkedIn
